Highlights
NASDAQ: ATHX       Athersys Inc
Last Price Today's Change   Day's Range   Trading Volume
1.395   -0.015 (1.06%)  1.39 - 1.41  370,277

Overview

 
Avg Volume (4 weeks):798,038
4 Weeks Range:1.19 - 1.41
4 Weeks Price Volatility (%):
93.18%
52 Weeks Range:1.16 - 2.03
52 Weeks Price Volatility (%):
27.01%
Average Price Target: 4.00
Price Target Upside/Downside: +2.605

Headlines



No recent Headlines for this stock.


Business Background

Athersys Inc is a clinical stage biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is significant unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

  Be the first to like this.
 


 

2271  3266  453  2974 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 GE 12.885+1.155 
 ACHN 6.760.00 
 AMD 46.66-3.87 
 AVP 5.60-0.05 
 CHK 0.557+0.038 
 AABA 19.630.00 
 VIAB 24.22+0.75 
 ECA 3.79-0.25 
 AAPL 327.16+9.47 
Partners & Brokers